United States Pharmaceutical Supply Chain Review Act This bill requires the Federal Trade Commission to submit annually to Congress a report on foreign investment in the U.S. pharmaceutical industry. The report shall address, among other topics, the effect of the industry's reliance on foreign manufacturing.
Congressional oversightGeneticsGovernment information and archivesGovernment studies and investigationsHealth technology, devices, suppliesIndustrial policy and productivityManufacturingPrescription drugsRetail and wholesale tradesU.S. and foreign investments
United States Pharmaceutical Supply Chain Review Act
USA117th CongressS-1367| Senate
| Updated: 4/26/2021
United States Pharmaceutical Supply Chain Review Act This bill requires the Federal Trade Commission to submit annually to Congress a report on foreign investment in the U.S. pharmaceutical industry. The report shall address, among other topics, the effect of the industry's reliance on foreign manufacturing.
Congressional oversightGeneticsGovernment information and archivesGovernment studies and investigationsHealth technology, devices, suppliesIndustrial policy and productivityManufacturingPrescription drugsRetail and wholesale tradesU.S. and foreign investments